Why long-horizon innovation needs more than good ideas
An analysis of what Australian long-horizon research commercialisation requires, citing Gilmour Space, Cochlear and BluGlass as illustrations of patient capital and ecosystem support needs.
Company
Every investor coverage indicates participated in a round Horizon Europe raised.
Companies Horizon Europe acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Horizon Europe. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
An analysis of what Australian long-horizon research commercialisation requires, citing Gilmour Space, Cochlear and BluGlass as illustrations of patient capital and ecosystem support needs.
Roundup of Australian manufacturing items: gold-nanoparticle cancer diagnostics research, a medical research endowment's ten-year mark, a footballer's ambassador role, EU research program accession talks, a pectin producer's government grant, and battle-tank trainers.
Titomic has received a European Union Horizon Europe CoBRAIN grant worth 260,000 Euro to fund AI and machine learning research into its cold spray manufacturing processes.